Evidence map›Paper›PMID 32443482›Full record

ReviewInternational journal of molecular sciences2020

The Role of T

Alicja Frączek, Agnieszka Owczarczyk-Saczonek, Waldemar Placek

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05506995 completednot on this mapstarted 2021, after this paper: background citation

Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo

TypeobservationalSponsorUniversidad Autonoma de San Luis PotosíRan2021 to 2022Enrolled11ConditionsVitiligo
NCT05698342 completednot on this mapstarted 2021, after this paper: background citation

Tissue-resident Memory T Cells Expression in Melasma

TypeobservationalSponsorUniversidad Autonoma de San Luis PotosíRan2021 to 2022Enrolled20ConditionsMelasma
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Treatment Advances in Vitiligo: An Updated Review.Dermatology practical & conceptual · 2025
    Review
  12. CD69Cell communication and signaling : CCS · 2024
    Article
  13. Article
  14. Review
  15. Etiopathogenesis and Emerging Methods for Treatment of Vitiligo.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alicja FrączekSchool of Medicine, Collegium Medicum, The University of Warmia and Mazury, 10-229 Olsztyn, Poland.
Agnieszka Owczarczyk-SaczonekSchool of Medicine, Collegium Medicum, The University of Warmia and Mazury, 10-229 Olsztyn, Poland.ORCID 0000-0002-8372-0438
Waldemar PlacekSchool of Medicine, Collegium Medicum, The University of Warmia and Mazury, 10-229 Olsztyn, Poland.
University of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitiligo is the most common hypopigmentation disease affecting both the skin and mucous membranes. The pathogenesis of this disorder is complex and involves the influence of genetic and environmental factors, oxidative stress, and autoimmune responses. Recent studies have indicated that skin lesions observed in vitiligo tend to recur in the same places where they were found before treatment. This phenomenon is explained by the presence of recently discovered tissue-resident memory T cells (T

Indexed as

Immunologic MemoryT-LymphocytesAnimalsAutoimmune DiseasesHumansInterleukin-15MelanocytesVitiligoInterleukin-15autoimmune diseasesIL-15tissue-resident memory T cellsvitiligo

Identifiers

PMID32443482
PMCPMC7278984
OpenAlexW3025037068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.